# ReST Therapeutics establishes U.S. headquarters in New Haven

Paris-based ReST Therapeutics chose New Haven, Connecticut for its U.S. headquarters, planning to invest $7.5 million and create 6 new jobs.

- Type: New facility
- Announced: 2023-12-19
- Where: New Haven, Connecticut, United States
- Value: $7.50M
- Jobs: 6
- Status: announced
- Products: therapies for neurological and psychiatric disorders
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ReST Therapeutics](https://endata.com/companies/74528.md)

## Sources

- [bdavison.bloxcms.com](https://bdavison.bloxcms.com/article_c17b0646-29eb-5b28-b4e5-26f730b14e3a.html), 2023-12-19: "Paris, France-based ReST Therapeutics recently announced its entry into the U.S. market by choosing New Haven as the location for its U.S. headquarters."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.